Skip to main content

Table 2 Baseline clinical characteristics and distribution by LTFU status of adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009–2016 (n = 305)

From: Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009–2016: survival model approach

Baseline characteristics

LTFU (n1 = 45) Frequency (%)

No-LTFU (n2 = 260) Frequency (%)

Total (n = 305) Frequency (%)

LTFU Rate [95%CI] Per 100 PYs

P-value

Body Mass Index (kg/m2)

0.0138

  > 17.4

17 (37.8)

131 (50.4)

148 (48.5)

3.0 [1.8, 4.8]

 

  < =17.4

28 (62.2)

129 (49.6)

157 (51.5)

6.6 [4.6, 9.6]

 

Functional Status

0.1476

 Working

17 (37.8)

124 (47.7)

141 (46.2)

3.2 [2.0, 5.2]

 

 Ambulatory

19 (42.2)

91 (35.0)

110 (36.1)

5.4 [3.5, 8.5]

 

 Bedridden

9 (20.0)

45 (17.3)

54 (17.7)

7.8 [3.4, 14.2]

 

 Clinical Stage

0.1093

 I or II

4 (8.9)

28 (10.8)

32 (10.5)

3.2 [1.2, 8.6]

 

 III

15 (33.3)

116 (44.6)

131 (42.9)

3.3 [2.0, 5.4]

 

 IV

26 (57.8)

116 (44.6)

142 (46.6)

6.3 [4.3, 9.3]

 

CD4 Count (Cells/mm3)

0.6213

  > 200

8 (17.8)

47 (18.1)

55 (18.0)

3.8 [1.9, 7.6]

 

  < =200

37 (82.2)

213 (81.9)

250 (82.0)

4.7 [3.4, 6.5]

 

Hemoglobin level (g/dl)

0.0002

 Normal (> 11.0)

19 (42.2)

172 (66.2)

191 (62.6)

2.8 [1.8, 4.3]

 

 Anemic (<=11.0)

26 (57.8)

88 (33.8)

114 (37.4)

8.5 [5.8, 12.5]